Looking to publish in International Journal of Gynecological Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThe International Journal of Gynecological Cancer (IJGC) serves as the primary educational and informational publication on topics related to the detection, prevention, diagnosis, and treatment of gynecologic malignancies. The content is intended for gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology. IJGC promotes a multidisciplinary approach and features original research, reviews, and video articles. IJGC is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
Looking to publish in International Journal of Gynecological Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
International Journal of Gynecological Cancer accepts the following article types. Click on an article type to view submission instructions.
Original Research
Review
Research Communication
Letter
Video Article
Clinical Trial
Recent Publications
Balancing Fertility Potential and Oncological and Obstetric Risks: A Vignette Study on Decision-Making in Fertility Sparing Surgery for Early-Stage Cervical Cancer
J.T. Wolswinkel, I. van Lenthe, J.S.F. Maurits, J.W.M. Aarts, R.L.M. Bekkers, M.L.G. Ten Eikelder, Y. Stroeken, J.J. Beltman, M.M. ter Kuile, C.A.R. Lok, N.E. van Trommel, J.C. Kasius, P.L.M. Zusterzeel
PRIMARY CERVICAL MELANOMA: Clinicopathologic features, immunohistochemical profile, and diagnostic considerations
Villegas-Cruz Carlos, Zalapa-Gómez María Fernanda, Salum-Rodríguez Lucy, Pérez-Saucedo José Eduardo
Beyond MEK Inhibition: Exploring MAPK Pathway Dependency in Low-Grade Serous Ovarian Carcinoma
Júlia Chain Martins, Ana Carolina Sousa Soares, Mariana Scaranti
In-transit lymph node metastases in ovarian pedicle in early stage ovarian cancer - Myth or reality?
Stoyan Kostov, Rafał Watrowski, Berta Díaz Feijoo, Nicolò Bizzarri, Denis Querleu
Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy
Matthew A. Powell, Sharad Ghamande, Lars C. Hanker, Destin Black, Nicoline Raaschou-Jensen, Lucy Gilbert, David Cibula, Angeles Alvarez Secord, Ana Oaknin, Robert W. Holloway, Hanne F. Mathiesen, Joseph Buscema, Rebecca Kristeleit, Sudarshan Sharma, Ingrid A. Boere, Brian Slomovitz, Christine Gennigens, Robert L. Coleman, Florian Heitz, Joyce N. Barlin, Siarhei Mavrichev, Jonathan Berek, Maria José Bermejo-Pérez, Johanne Weberpals, Antonella Savarese, Suzanne Maret, Kaitlin Yablonski, Rosemary Schroyer, Laura Austin, Giorgio Valabrega, Trine Nøttrup
Frequently asked questions
How long does it take to publish?
Median 7 days from submission to first decision.
Reformat to International Journal of Gynecological Cancer using Livewrite PremiumIs a cover letter required?
Tumor Board submissions require a letter of intent to the Editor-in-Chief before invitation to submit. If photos are included in a Video Article, the cover letter should indicate that express permission was obtained from all pictured individuals.
Reformat to International Journal of Gynecological Cancer using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3800 excluding taxes for all articles. Subscription publication has no open access publication fee. ESGO and IGCS corresponding authors receive a 25% APC discount.
Reformat to International Journal of Gynecological Cancer using Livewrite Premium